What is the recommended dose of Insulatard (NPH insulin) for a patient with a blood glucose level of 309 mg/dL?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Immediate Insulin Dose Adjustment for Blood Glucose of 309 mg/dL

For a blood glucose of 309 mg/dL on Insulatard (NPH insulin), increase the dose by 4 units every 3 days until fasting glucose reaches 80-130 mg/dL, and add correction insulin immediately using a sliding scale approach. 1

Understanding Your Current Situation

Your blood glucose of 309 mg/dL indicates inadequate basal insulin coverage and requires aggressive titration. 1 The target fasting glucose should be 80-130 mg/dL. 1

Immediate NPH Insulin Adjustment

  • Increase your current NPH dose by 4 units every 3 days when fasting glucose is ≥180 mg/dL (which 309 mg/dL clearly exceeds). 1, 2
  • Continue this aggressive titration until your fasting glucose consistently reaches 80-130 mg/dL. 1
  • If you experience hypoglycemia (blood glucose <70 mg/dL) without clear cause, reduce the dose by 10-20% immediately. 1

Correction Insulin Protocol

For immediate management of your current hyperglycemia, implement this correction scale with regular insulin or rapid-acting insulin:

  • Blood glucose 150-200 mg/dL: 2 units 3
  • Blood glucose 201-250 mg/dL: 4 units 3
  • Blood glucose 251-300 mg/dL: 6 units 3
  • Blood glucose 301-350 mg/dL: 8 units 3
  • Blood glucose >350 mg/dL: 10 units and notify provider 3

Based on your current glucose of 309 mg/dL, you would take 6 units of correction insulin now. 3

Critical Threshold Monitoring

  • When your NPH dose exceeds 0.5 units/kg/day and approaches 1.0 units/kg/day without achieving glycemic targets, adding prandial (mealtime) insulin becomes more appropriate than continuing to escalate NPH alone. 1, 2
  • Watch for signs of "overbasalization": bedtime-to-morning glucose differential ≥50 mg/dL, hypoglycemia episodes, or high glucose variability throughout the day. 1

Daily Monitoring Requirements

  • Check fasting blood glucose every morning during this titration phase. 1
  • Record all glucose values to guide dose adjustments every 3 days. 1
  • Monitor for hypoglycemia symptoms: shakiness, sweating, confusion, rapid heartbeat. 1

Foundation Therapy

  • Continue metformin (if you're taking it) unless contraindicated, as this combination provides superior glycemic control with reduced insulin requirements. 2
  • Metformin should be at maximum tolerated dose (up to 2000-2550 mg daily). 2

When to Add Mealtime Insulin

If after optimizing your NPH dose (achieving fasting glucose 80-130 mg/dL) your HbA1c remains above target after 3-6 months, you will need to add prandial insulin:

  • Start with 4 units of rapid-acting insulin before the largest meal. 1
  • Alternatively, use 10% of your current NPH dose as the starting prandial dose. 1
  • Titrate prandial insulin by 1-2 units every 3 days based on 2-hour post-meal glucose readings. 1

Common Pitfalls to Avoid

  • Do not wait longer than 3 days between NPH adjustments in stable conditions, as this unnecessarily prolongs time to achieve glycemic targets. 1
  • Do not continue escalating NPH beyond 0.5-1.0 units/kg/day without addressing post-meal hyperglycemia, as this leads to overbasalization with increased hypoglycemia risk. 1, 2
  • Never use correction insulin alone as your only treatment—you need scheduled basal insulin (NPH) as the foundation. 2

Hypoglycemia Management

  • Treat any glucose <70 mg/dL immediately with 15 grams of fast-acting carbohydrate (3-4 glucose tablets, 4 oz juice, or 1 tablespoon honey). 1
  • Recheck glucose in 15 minutes and repeat treatment if still <70 mg/dL. 1
  • Always carry fast-acting carbohydrates with you. 1

When to Contact Your Healthcare Provider

  • If fasting glucose remains >180 mg/dL after 2-3 weeks of titration. 1
  • If you experience repeated hypoglycemia episodes. 1
  • If your NPH dose exceeds 0.5 units/kg/day without achieving fasting glucose targets. 1

References

Guideline

Management of Steroid-Induced Hyperglycemia with NPH Insulin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Initial Dosing for Lantus (Insulin Glargine) in Patients Requiring Insulin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Hyperglycemia in Post-Kidney Transplant Patients on High-Dose Steroids

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.